Earnings Feed
Start Free
Salarius Pharmaceuticals, Inc.·4

Jan 21, 4:05 PM ET

Lammers Paul 4

4 · Salarius Pharmaceuticals, Inc. · Filed Jan 21, 2022

Insider Transaction Report

Form 4
Period: 2022-01-20
Salarius Pharmaceuticals, Inc.SLRX
Lammers Paul
Director
Transactions
  • Award

    Stock Option (right to buy)

    2022-01-20+30,000→ 30,000 total
    Exercise: $0.48From: 2023-01-19Exp: 2032-01-19→ Common Stock (30,000 underlying)

Documents

1 file
  • 4
    wf-form4_164279908733608.xmlPrimary

    FORM 4